The controversial role of surgery in stage III NSCLC

The Lancet Oncology

Volumn 9, Issue 7, 2008, Pages 607-608

  van Meerbeeck, Jan P ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PLATINUM COMPLEX;

CANCER CLASSIFICATION; CANCER INVASION; CANCER STAGING; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DISEASE FREE SURVIVAL; HUMAN; LETTER; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG SURGERY; OVERALL SURVIVAL; PLEURA EFFUSION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; SURGICAL MORTALITY; TUMOR REGRESSION;

CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; PNEUMONECTOMY; RADIOTHERAPY, ADJUVANT;

EID: 45849091827     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(08)70161-X     Document Type: Letter

References (11)

1. Mountain C. The international system for staging lung cancer. Chest 111 (1997) 1710-1717
2. Thomas M., Rübe C., Hoffknecht P., et al. Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non-small-cell lung cancer. Lancet Oncol 9 (2008) 636-648
3. Treasure T., and Utley M. Ten traps for the unwary in surgical series: a case study in mesothelioma reports. J Thorac Cardiovasc Surg 133 (2007) 1414-1418
4. Robinson L., Ruckdeschel J., Wagner H., and Stevens C. Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines, 2nd edition. Chest 132 (2007) 243-265
5. Patel V., and Shrager J. Which patients with stage III non-small cell lung cancer should undergo surgical resection?. Oncologist 10 (2005) 335-344
6. Mountain C. A new international staging system for lung cancer. Chest 89 (1986) 225-233
7. Goldstraw P., Crowley J., Chansky K., et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2 (2007) 705-714
8. Feinstein A., Sosin D., and Wells C. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 312 (1985) 1604-1608
9. Morgensztern D., Goodgame B., Baggstrom M., et al. The effect of FDG-PET on the stage distribution of non-small cell lung cancer. J Thorac Oncol 3 (2008) 135-139
10. van Meerbeeck J., Meersschaut S., De Pauw R., et al. Modern radiotherapy as part of combined modality treatment in locally advanced non-small cell lung cancer: present status and future prospects. Oncologist 13 (2008) 700-708
11. Belani C., Wang W., Johnson D., et al. Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597): induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer. J Clin Oncol 23 (2005) 3760-3767